Join Us

Join Fenwick for an insightful webinar discussing the USPTO’s recent guidance on the patentability of AI-assisted inventions and what it means for the life sciences industry.

Our Life Sciences and Intellectual Property lawyers will explore what the guidance means for the use of AI in the composition of new drug compounds, biomarker discovery, and diagnostics, including:

• What is and isn’t covered under the USPTO’s guidance.
• What precautions companies should take to make sure they have coverage.
• Successful patent strategies and potential pitfalls in AI-assisted drug discovery cases.

This webinar will be recorded and is eligible for CLE credit.

If you have any questions, please contact Bridget-Marie Basile or +1 646-940-8003.

Speakers

Agenda